Treace Medical Concepts Inc.
Treace Medical Concepts Inc. (TMCI): 1 pipeline candidate · ~4 mo cash runway · 4 clinical trials. Updated within the last hour.
BioSniper Score
5-factor signal · derived from public data
3.9 months
D/E 1.39
Lead: Approved
1 candidate
N/A
7 buys · 0 sells (180d)
A transparent, data-derived signal for Treace Medical Concepts Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$267.3M
Cash
$9.5M
Quarterly Burn
$54.6M
Runway
3.9 mo
Revenue
$47.2M
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (1 candidate)
| Drug | Phase |
|---|---|
| lapiplasty | Approved |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
116
Total value held
$46.8M
| Holder | Shares | Value |
|---|---|---|
| armistice capital, llc | 6,364,000 | $8.5M |
| gagnon securities llc | 5,201,886 | $7.0M |
| blackrock, inc. | 3,340,023 | $4.5M |
| bank of america corp /de/ | 3,214,293 | $4.3M |
| vanguard capital management llc | 2,923,014 | $3.9M |
| state street corp | 1,235,518 | $1.7M |
| millennium management llc | 1,148,115 | $1.5M |
| aqr capital management llc | 1,061,840 | $1.4M |
| geode capital management, llc | 1,010,843 | $1.4M |
| d. e. shaw & co., inc. | 841,269 | $1.1M |
Showing top 10 of 116 institutional holders of Treace Medical Concepts Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in Treace Medical Concepts Inc.'s pipeline?
Treace Medical Concepts Inc. (TMCI) has 1 pipeline candidate tracked by BioSniper across SEC filings and clinical trial registrations.
What is Treace Medical Concepts Inc.'s lead drug candidate?
Treace Medical Concepts Inc.'s most advanced tracked candidate is lapiplasty (Approved) for Bunions.
What is Treace Medical Concepts Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Treace Medical Concepts Inc. has approximately 3.9 months of cash runway.
What is Treace Medical Concepts Inc.'s market capitalization?
Treace Medical Concepts Inc.'s market capitalization is approximately $267.3M.
Who is the CEO of Treace Medical Concepts Inc.?
Mr. John T. Treace is the chief executive officer of Treace Medical Concepts Inc. (TMCI).
Get the full picture on Treace Medical Concepts Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.